Valuation: IRADIMED CORPORATION

Market Cap 120.26Cr 105.77Cr 98Cr 90Cr 169.48Cr 12TCr 172.52Cr 1.18TCr 458.31Cr 5.68TCr 451.49Cr 441.73Cr 20TCr P/E 2026 *
49.3x
P/E 2027 * 43.5x
Enterprise Value 120.26Cr 105.77Cr 98Cr 90Cr 169.48Cr 12TCr 172.52Cr 1.18TCr 458.31Cr 5.68TCr 451.49Cr 441.73Cr 20TCr EV / Sales 2026 *
13.2x
EV / Sales 2027 * 11.9x
Free-Float
64.8%
Yield 2026 *
-
Yield 2027 * -
1 day-0.64%
1 week-4.42%
Current month-2.21%
1 month+1.18%
3 months+5.24%
6 months-7.35%
Current year-3.94%
1 week 92.76
Extreme 92.765
98.46
1 month 90.83
Extreme 90.83
102.99
Current year 76.95
Extreme 76.95
107.9
1 year 55.11
Extreme 55.1093
107.9
3 years 36.12
Extreme 36.12
107.9
5 years 26
Extreme 26
107.9
10 years 7.85
Extreme 7.85
107.9
Manager TitleAgeSince
Chief Executive Officer 72 28/05/2020
Director of Finance/CFO 64 20/06/2022
Chief Tech/Sci/R&D Officer - 01/01/2020
Director TitleAgeSince
Chairman 72 16/06/2020
Director/Board Member 70 01/01/2019
Director/Board Member 73 01/01/2014
Date Insider Type Main position Quantity % Market Cap.
20/06/26 Fiscal year

Chief Financial Officer

13,911 0.1088%
04/06/26 Sell

Director

-3,000 0.0235%
01/06/26 Sell

Chief Executive Officer

-2,500 0.0196%
Change 5-day change 1-year change 3-year change Capi.($)
-0.61%-4.42%+63.95%+106.02% 120.26Cr
+0.01%+4.45%-14.78%-16.59% 1.38TCr
+1.52%-8.34%+40.09%-8.60% 388.53Cr
-3.05%-2.34%-38.13%-60.52% 121.46Cr
+0.19%-2.78%-41.32%-47.39% 108.6Cr
+0.34%+2.35%-42.93% - 93Cr
+2.37%-14.11%+49.28%+79.71% 46Cr
-5.43%+2.82%+54.59% - 35Cr
-0.21%+0.88%-58.49%+234.80% 26Cr
-2.45%-8.64%+20.66%+38.25% 14Cr
Average -0.74%+0.00%+3.29%+40.71% 233.13Cr
Weighted average by Cap. +0.04%+2.14%-3.15%-7.09%

Financials

2026 *2027 *
Net sales 9.12Cr 8.02Cr 7.45Cr 6.85Cr 13Cr 883.2Cr 13Cr 89Cr 35Cr 430.79Cr 34Cr 33Cr 1.49TCr 10Cr 8.87Cr 8.24Cr 7.58Cr 14Cr 977.13Cr 14Cr 99Cr 38Cr 476.6Cr 38Cr 37Cr 1.65TCr
Net income 2.46Cr 2.16Cr 2.01Cr 1.84Cr 3.46Cr 237.75Cr 3.52Cr 24Cr 9.36Cr 115.96Cr 9.22Cr 9.02Cr 402.31Cr 2.78Cr 2.45Cr 2.27Cr 2.09Cr 3.92Cr 269.22Cr 3.99Cr 27Cr 11Cr 131.31Cr 10Cr 10Cr 455.57Cr
Net Debt - -
Logo IRADIMED CORPORATION
IRadimed Corporation develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and accessories, disposables and services. Its MRidium 3870 MRI Compatible IV infusion pump system provides a non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium 3860+ MRI Compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to safely and predictably and other IV fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to safely and accurately during various MRI procedures. The Company sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably on magnetic fields of over 30,000 gauss.
Employees
166
Date Price Change Volume
23/26/23 $93.45 -0.67% 59,300
22/26/22 $94.08 -0.94% 91,871
21/26/21 $94.97 -2.12% 1,26,070
20/26/20 $97.03 0.00% 75,920
17/26/17 $97.03 -0.76% 1,29,671
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
94.08USD
Average target price
118.00USD
Spread / Average Target
+25.43%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IRMD Stock